Amylyx Pharmaceuticals, Inc. AMLX
Set alert
28.86 USD +0.18 +0.63%
At close
29.30 +0.44 +1.52%
Pre-market · Nov 2, 7:05 AM ET
28.00 Day range 29.09
10.83 52-week range 41.14
- YTD
- +138.91%
- 1 year
- +105.41%
- Open
- 28.41
- Prev close
- 28.68
- Mkt cap
- 3.62B
- Vol
- 774.15K
- Avg vol
- 2.19M
- EPS
- -1.41
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 28.00
- High
- 29.09
- Forward P/E
- -26.47
- Beta
- -0.09
- Short ratio
- 9.49
- Inst. own
- 94.37%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 31.11
- 200-d avg
- 20.00
- 1y target
- 43.00
Ownership
Held by insiders 7.16%
Held by institutions 94.37%
Float held by institutions 101.64%
Institutions 288
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 15.01% | 16,727,909 | 482.77M | Jun 29, 2026 |
| Blackrock Inc. | 7.92% | 8,827,085 | 254.75M | Jun 29, 2026 |
| Perceptive Advisors Llc | 7.48% | 8,334,882 | 240.54M | Jun 29, 2026 |
| TCG Crossover Management, LLC | 5.60% | 6,243,812 | 180.20M | Jun 29, 2026 |
| Commodore Capital Lp | 5.07% | 5,650,000 | 163.06M | Jun 29, 2026 |
| Jupiter Topco LLC | 4.70% | 5,236,102 | 151.11M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.83% | 3,154,723 | 91.05M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.42% | 2,694,093 | 77.75M | Sep 29, 2026 |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 2.18% | 2,433,200 | 70.22M | Aug 30, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 1.90% | 2,115,961 | 61.07M | Jul 30, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.44% | 1,600,000 | 46.18M | Aug 30, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.32% | 1,470,117 | 42.43M | Aug 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEDROSIAN CAMILLE L | Officer | Sale | Sep 9, 2026 | 278,064 |
| COHEN JOSHUA BARRY | Chief Executive Officer | Sale | Sep 9, 2026 | 3,613,120 |
| FIRESTONE KAREN M. | Director | Conversion of Exercise of derivative security | Aug 30, 2026 | 116,900 |
| FRATES JAMES MATTHEW | Chief Financial Officer | Sale | Sep 9, 2026 | 400,156 |
| KLEE JUSTIN B | Chief Executive Officer | Sale | Sep 9, 2026 | 3,613,060 |
| MAZZARIELLO GINA | Officer | Sale | Sep 9, 2026 | 190,838 |
Held by funds
121 US ETFs and mutual funds hold AMLX · largest positions